Health Policy and Health Services

Health policy and health services research examines the effect of health policies and system-based approaches on the risks and outcomes of type 2 diabetes for various population groups.

Health Policy and Health Services Study

Natural Experiments for Translation in Diabetes 2 (NEXT-D2) Study

Overall Objective: The overall objective of the NEXT-D2 Study is to examine the effect of major population-targeted policies and interventions on diabetes prevention and control. NEXT-D2 is a follow-up to the NEXT-D Study, which rigorously evaluated health policies and interventions used by health care systems, businesses, and communities and mandated by health care legislation as a way to reduce diabetes risk, complications, and health inequalities across broad segments of the US population.

Funding Agencies:

• CDC, DDT
• NIH, National Institute of Diabetes & Digestive & Kidney Diseases

Period of Funding: 11/01/15–10/30/20

Grantees:

• Oregon Health Sciences University: Post ACA Reform: Evaluation of Community Health Center Care of Diabetes (PREVENT-D)
• NW: The Effect of ACA Medicaid Expansion on Diabetes: Diagnosis, Treatment, and Health Outcomes
• UC Berkeley: State Innovation Model Initiative Impacts on Diabetes Prevention and Management
• UCLA: A Partnered Evaluation of UHC Medicaid Plan Innovations for Diabetes Patients
• Harvard Pilgrim: Impact of Health Savings Account Cost-sharing Reductions on Diabetes Care
• Tulane: Impact of a CMS Reimbursement Policy Supporting Care Coordination in Louisiana
• PSU: A Patient-Centered Path to Addressing Diabetes

Selected Publications:

1. Gregg EW, Ali MK, Moore BA, et al. The importance of natural experiments in diabetes prevention and control and the need for better health policy research. Prev Chronic Dis. 2013;10:E14. doi: 10.5888/pcd10.120145
2. Ackermann RT, Kenrik Duru O, Albu JB, et al. Evaluating diabetes health policies using natural experiments: the natural experiments for translation in diabetes study. Am J Prev Med. 2015;48(6):747–754.
3. Soumerai SB, Starr D, Majumdar SR. How do you know which health care effectiveness research you can trust? A guide to study design for the perplexed. Prev Chronic Dis. 2015;12:E101. doi: 10.5888/pcd12.150187.
4. Wharam JF, Soumerai S, Trinacty C, et al. Impact of emerging health insurance arrangements on diabetes outcomes and disparities: rationale and study design. Prev Chronic Dis. 2013;10:E11. doi: 10.5888/pcd10.120147.
5. Schmittdiel JA, Brown SD, Neugebauer R, et al. Health-plan and employer-based wellness programs to reduce diabetes risk: the Kaiser Permanente Northern California NEXT-D Study. Prev Chronic Dis. 2013;10:E15.
6. Adams SR, Wiley DM, Fargeix A, George V, Neugebauer RS, Schmittdiel JA. Employer-based screening for diabetes and prediabetes in an integrated health care delivery system: a Natural Experiment for Translation in Diabetes (NEXT-D) Study. J Occup Environ Med. 2015;57(11):1147–1153.
7. Freudenberg N, Franzosa E, Sohler N, Li R, Devlin H, Albu J. The state of evaluation research on food policies to reduce obesity and diabetes among adults in the United States, 2000-2011. Prev Chronic Dis. 2015;12:E182.
8. Sohler N, Matti-Orozco B, Young E, et al. Opportunistic screening for diabetes and prediabetes using hemoglobin A1C in an urban primary care setting. Endocr Pract. 2016;22(2):143–150.
9. Duru OK, Turk N, Ettner SL, et al. Adherence to metformin, statins, and ACE/ARBs within the Diabetes Health Plan (DHP). J Gen Intern Med. 2015;30(11):1645–1650. doi: 10.1007/s11606-015-3284-8.
10. Moin T, Li J, Duru OK, et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med. 2015;162(8):542–548.